Primary Cutaneous Large B-Cell Lymphoma Shows Activation of Nuclear Factor Kappa B and Low Incidence of Epstein-Barr Virus
- 1 July 2010
- journal article
- research article
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 32 (5) , 439-441
Abstract
Primary cutaneous lymphomas are defined as lymphomas, which are present in the skin without evidence of extracutaneous disease at the time of diagnosis. Primary cutaneous large B-cell lymphoma (PCLBCL) is a subtype of primary cutaneous B-cell lymphoma with a female predominance, occurring in elderly patients and known to have unfavorable prognosis. We evaluated 10 cases of PCLBCL in immunocompetent patients between 2005 and 2008. A panel of immuoperoxidase stains; CD3, CD10, CD20, BCL2, BCL6, and MUM1 were performed on all cases. Nuclear factor kappa B (NF-κB) pathway activation was evaluated using an immunostain for P65. The presence of Epstein-Barr virus (EBV) was assessed using Epstein-Barr virus encoded RNA (EBER) in situ hybridization probe. All cases were CD20 positive and CD3 negative. CD10, BCL6, BCL2, and MUM1 were positive in 4/10 (40%), 6/10 (60%), 7/10 (70%), and 7/10 (70%) cases, respectively. NF-κB activation was detected in 7/10 (70%) cases. One (10%) case was positive for EBV by in situ hybridization. Interestingly, the EBV positive case was also positive for MUM1 and negative for CD10, indicating an activated immunophenotype. In conclusion, majority of PCLBCL shows activation of NF-κB pathway with a low incidence of EBV.Keywords
This publication has 12 references indexed in Scilit:
- EBV positivity in primary cutaneous large B-cell lymphoma with immunophenotypic features of leg type: An isolated incidence or something more significant?Acta Oncologica, 2008
- Aberrant NF-κB signaling in lymphoma: mechanisms, consequences, and therapeutic implicationsBlood, 2006
- Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patientsBlood, 2005
- WHO-EORTC classification for cutaneous lymphomasBlood, 2005
- Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profilingBlood, 2005
- Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patientsBlood, 2002
- Constitutive Nuclear Factor κB Activity Is Required for Survival of Activated B Cell–like Diffuse Large B Cell Lymphoma CellsJournal of Experimental Medicine, 2001
- Prognostic Factors in Primary Cutaneous Large B-Cell Lymphomas: A European Multicenter StudyJournal of Clinical Oncology, 2001
- Cancer Surveillance Series: Non-Hodgkin's Lymphoma Incidence by Histologic Subtype in the United States From 1978 Through 1995JNCI: Journal of the National Cancer Institute, 2000
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000